Monicah Otieno

Monicah Otieno has a diverse work experience in the pharmaceutical industry. In their current position as the Head of Toxicology at Bill & Melinda Gates Medical Research Institute, they have been leading the toxicology department since January 2020. Prior to this, they worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Senior Scientific Director for seven years, from April 2012 to November 2019. During their time there, they had extensive experience in non-clinical safety, toxicology, pharmacology, physiology, and drug metabolism & pharmacokinetics. Before joining Janssen, Monicah worked at Bristol-Myers Squibb as a Principal Scientist from August 2007 to April 2012, specializing in discovery/development toxicology and mechanistic & investigative toxicology. Monicah began their career at AstraZeneca as a Principal Scientist II from April 2001 to July 2007.

Monicah Otieno's education history began with their enrollment in the University of Rochester School of Medicine and Dentistry, where they pursued a Doctor of Philosophy (PhD) degree in Pharmacology. Monicah completed this program in an unspecified year prior to 1997. Following their PhD, Monicah then pursued a post-doctoral fellowship at the Johns Hopkins Bloomberg School of Public Health, specializing in Toxicology. Monicah completed this fellowship in 2001. In 2016, Monicah participated in the Women's Leadership Development Program at Smith College, though no specific field of study is mentioned for this program.